NCT00061945 2022-05-03
Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
Phase 1/2 Completed
Clinical Trials
1 trialsNIH × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Trimethoprim, Sulfamethoxazole Drug Combination × Clear all